Figure 7.

Alternative 5′ss and 3′ss usage caused by Anti-N1 treatment. (A). The sequence context of two alternative 5′ss of 10 candidate exons whose usage either increased or decreased upon Anti-N1 treatment. At the right of each sequence, the predicted strength of each 5′ss is shown. ∆SI indicates the change in proportional usage of the shorter isoform upon Anti-N1 treatment. Other coloring and labeling are the same as in Figure 3A. (B). Genomic views of the alternative 5′ss shown in panel A. Red arrows indicate the 5′ss with decreased usage, green arrows, the 5′ss with increased usage. Other labeling and coloring are the same as in Figure 3C and Figure 6B. (C). The sequence context of two alternative 3′ss of 10 candidate exons whose usage either increased or decreased upon Anti-N1 treatment. Other table contents and annotation are the same as in Figure 3A. (D). Genomic views of the alternative 3′ss shown in panel C. Red arrows indicate the 3′ss with decreased usage, and green arrows the 3′ss with increased usage. Other coloring and labeling are the same as in Figure 3C and Figure 6B.